GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PTCT
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Stronger technical forecast for PTC Therapeutics stock price after Friday trading.
(Updated on Apr 19, 2024)

Hold candidate since Apr 19, 2024 PDF

The PTC Therapeutics stock price gained 2.55% on the last trading day (Friday, 19th Apr 2024), rising from $24.69 to $25.32. During the last trading day the stock fluctuated 6.41% from a day low at $24.01 to a day high of $25.55. The price has fallen in 7 of the last 10 days and is down by -6.29% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 3 million more shares were traded than the day before. In total, 4 million shares were bought and sold for approximately $99.55 million.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $24.71 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 4.20% during the next 3 months and, with a 90% probability hold a price between $25.75 and $34.04 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PTCT Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 2.55%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The PTC Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $25.71 and $28.70. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for PTC Therapeutics stock

PTC Therapeutics finds support from accumulated volume at $25.04 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.54 between high and low, or 6.41%. For the last week, the stock has had daily average volatility of 4.50%.

Our recommended stop-loss: $23.95 (-5.43%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 1 day ago.)

Trading Expectations (PTCT) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect PTC Therapeutics to open at $24.96, and during the day (based on 14 day Average True Range), to move between $23.98 and $26.66, which gives a possible trading interval of +/-$1.34 (+/-5.29%) up or down from last closing price. If PTC Therapeutics takes out the full calculated possible swing range there will be an estimated 10.58% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $25.04 (1.11%) than the resistance at $27.05 (6.83%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

PTC Therapeutics will release earnings AMC on Thursday, April 25, 2024.The consensus among the analysts for the expected earnings (EPS) is -$1.31. We will update the financials statements for PTC Therapeutics, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 4.69% in the first trading day after earnings release.

Is PTC Therapeutics stock A Buy?

PTC Therapeutics holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.278 Hold/Accumulate Upgraded

Predicted Opening Price for PTC Therapeutics of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$24.96 ( 1.42%) $25.32

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PTCT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 26.50 4.66 %
R2 25.91 2.34 %
R1 25.55 0.90 %
Current price: 25.32
Support S1 24.37 -3.75 %
S2 24.01 -5.18 %
S3 23.42 -7.50 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 29.55 16.71 %
R2 28.19 11.33 %
R1 27.05 6.83 %
Current price 25.32
Support S1 25.04 -1.11%
S2 24.69 -2.49%
S3 24.15 -4.62%

FAQ

What is the symbol for PTC Therapeutics Stock and on which exchange is it traded?
The symbol for PTC Therapeutics is PTCT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell PTC Therapeutics Stock?
PTC Therapeutics holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy PTC Therapeutics Stock?
PTC Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy PTC Therapeutics Stock.

What's the current price of PTC Therapeutics Stock?
As of the end of day on the 2024-04-19, the price of an PTC Therapeutics (PTCT) share was $25.32.

What is the 52-week high and low for PTC Therapeutics Stock?
The 52-week high for PTC Therapeutics Stock is $59.75 and the 52-week low is $17.53.

What is the market capitalization of PTC Therapeutics Stock?
As of the 2024-04-19, the market capitalization of PTC Therapeutics is 1.94B.

When is the next earnings date for PTC Therapeutics?
The upcoming earnings date for PTC Therapeutics is Apr 25, 2024.
Click to get the best stock tips daily for free!

About PTC Therapeutics

PTC Therapeutics PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple therapeutic areas, such as rare diseases. The company offer... PTCT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT